Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
about
Gene therapy for lower urinary tract dysfunctionRegenerative therapies for diabetic microangiopathyThe partitioning of nanoparticles to endothelium or interstitium during ultrasound-microbubble-targeted delivery depends on peak-negative pressure.Mechanisms of Amplified Arteriogenesis in Collateral Artery Segments Exposed to Reversed Flow Direction.Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit.Miniaturization: an overview of biotechnologies for monitoring the physiology and pathophysiology of rodent animal models.Assessment of myocardial blood perfusion improved by CD151 in a pig myocardial infarction model.Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease.Gene therapy in the treatment of peripheral arterial disease.Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia modelAngiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.Gene therapy using hepatocyte growth factor expressing adenovirus improves skin flap survival in a rat model.Interleukin-19 increases angiogenesis in ischemic hind limbs by direct effects on both endothelial cells and macrophage polarization.Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy.Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular disease.Does gene therapy become pharmacotherapy?Hepatocyte growth factor as potential cardiovascular therapy.Attenuation of limb loss in an experimentally induced hindlimb ischemic model by fibroblast growth factor-2/fragmin/protamine microparticles as a delivery systemStudy on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D.Hypoxia-inducible factor-1α and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats.Percutaneous nonviral delivery of hepatocyte growth factor in an osteotomy gap promotes bone repair in rabbits: a preliminary study.Exercise training and peripheral arterial disease.T Cell Deficits and Overexpression of Hepatocyte Growth Factor in Anti-inflammatory Circulating Monocytes of Middle-Aged Patients with Bipolar Disorder Characterized by a High Prevalence of the Metabolic Syndrome.Concise review: cell therapy and tissue engineering for cardiovascular disease.Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success.Beperminogene perplasmid for the treatment of critical limb ischemia.Hepatocyte growth factor and Met in drug discovery.Current therapies and investigational drugs for peripheral arterial disease.Regenerative therapies using cell sheet-based tissue engineering for cardiac disease.Notch signaling in cerebrovascular diseases (Review)Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study.Recent progress in therapeutic angiogenesis.Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia.Efficient expression of vascular endothelial growth factor using minicircle DNA for angiogenic gene therapy.Isolation, culture and detection of mesenchymal stem cells in tissues from critical limb ischemia model in rat.Hepatocyte growth factor protects small airway epithelial cells from apoptosis induced by tumor necrosis factor-alpha or oxidative stress.Pan-PPAR Agonist, Bezafibrate, Restores Angiogenesis in Hindlimb Ischemia in Normal and Diabetic Rats.
P2860
Q26824783-B6F4A846-8AF0-4F26-9962-E58A61A0EA29Q27027852-AD3EED66-ED64-4296-8513-779B6409635AQ30278047-A3B42621-097A-4E89-BAAA-5716062927A6Q30278752-A4B5838E-F7AC-4B05-B19D-4D80E7921A4EQ30354271-D0206B72-586F-4476-B187-0FCF908607BDQ30892610-9C14FDBB-0D8C-4EBC-92A6-CDEEC02F209DQ31095403-CFA878BD-14F1-4D71-9034-BF843B82D0D8Q33552206-C4255144-DBD7-4047-8A31-7803F25395C8Q33965740-378F24C2-0125-45E8-B06C-9707287EAC2EQ34070287-95AC5978-F06E-4D50-A51F-E8E6352A0066Q34460354-5795DAC4-A00F-4B66-8D23-D551102FF9FCQ34515181-6ABE43B1-EBCB-4173-A0F5-CF3A5E6926C7Q34588837-29F4B264-DAD7-4B36-8010-5A6600C9883AQ34995710-2E62DFDC-460F-48A9-ADFC-3F7E6D629E22Q35069562-B03D9028-59F4-4B6F-99D1-C46B29680083Q35619182-572854B3-5367-49F5-A3F3-474ACB2D7236Q35814460-736109FD-5DDF-4C09-9C52-F11E4E789784Q36075155-00BBCB9C-917A-4FE0-A782-8E72F11E67ACQ36124924-A7E915FF-3A23-4559-9640-A5A4A8762EFEQ36352469-5714FD53-EF41-4227-8531-095A395249EEQ36466672-11FC57B2-9CAF-4995-8177-5C0DD4A9625BQ36787101-1DAF8B0D-837B-45D3-82B9-B1BC557610C6Q37065913-674F1359-67B0-42C0-98CA-0B79899B9D4FQ37157213-6D19178A-9ACA-49CC-B3E6-42238329F95CQ37710533-4B4C09A3-5DC6-4E9F-82CE-FAC1382D1BADQ38063849-8E3928BF-298C-4C4D-A8BE-4A1D1481B881Q38087578-9A9F3FE5-1721-42FF-96F0-129E47DEA170Q38246211-B604BFF4-BC5A-40F9-B1B4-04BD7849CF18Q38377273-939E75B7-61B9-4D23-BFAD-60F81034F372Q38657444-0993E3DA-74F1-4F43-B848-47A03A7B590EQ38658511-ABA4BE17-F0F8-409A-972D-980E9CC5251DQ38940654-E9DE54CE-4D12-4E1E-8518-4167E567A084Q39240834-9CAA810B-F075-4C4D-BD18-C64F03AF482EQ39320424-03EA7970-2E55-4D28-929D-6A18BA1DD105Q39526666-2D1D50C0-ED48-4728-AC9F-63DB0D1DD506Q39674129-EC8C5383-B8F4-4A99-9B6A-AAD83D65C778Q40038726-CAA36B69-25C3-4D2D-A5AF-5A97559CB3DCQ40363198-396EBA94-E9D5-4B9B-8C89-3325CD749BE7Q40544580-CFB9ED92-47DD-434C-9B4F-E23BF3890F86Q41876722-1CF43BDF-67AD-4006-A881-CEA3D52B0261
P2860
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Therapeutic angiogenesis induc ...... f peripheral arterial disease.
@ast
Therapeutic angiogenesis induc ...... f peripheral arterial disease.
@en
type
label
Therapeutic angiogenesis induc ...... f peripheral arterial disease.
@ast
Therapeutic angiogenesis induc ...... f peripheral arterial disease.
@en
prefLabel
Therapeutic angiogenesis induc ...... f peripheral arterial disease.
@ast
Therapeutic angiogenesis induc ...... f peripheral arterial disease.
@en
P2093
P2860
P356
P1433
P1476
Therapeutic angiogenesis induc ...... f peripheral arterial disease.
@en
P2093
Matsumoto K
Morishita R
Nakamura T
Taniyama Y
Yamamoto K
Yamazaki K
P2860
P2888
P304
P356
10.1038/SJ.GT.3301379
P577
2001-02-01T00:00:00Z
P5875
P6179
1017345851